216 related articles for article (PubMed ID: 30060076)
1. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.
Gu F; Chen TH; Pfeiffer RM; Fargnoli MC; Calista D; Ghiorzo P; Peris K; Puig S; Menin C; De Nicolo A; Rodolfo M; Pellegrini C; Pastorino L; Evangelou E; Zhang T; Hua X; DellaValle CT; Timothy Bishop D; MacGregor S; Iles MI; Law MH; Cust A; Brown KM; Stratigos AJ; Nagore E; Chanock S; Shi J; Consortium MM; Consortium M; Landi MT
Hum Mol Genet; 2018 Dec; 27(23):4145-4156. PubMed ID: 30060076
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
3. Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts.
Steinberg J; Iles MM; Lee JY; Wang X; Law MH; Smit AK; Nguyen-Dumont T; Giles GG; Southey MC; Milne RL; Mann GJ; Bishop DT; MacInnis RJ; Cust AE
Br J Dermatol; 2022 May; 186(5):823-834. PubMed ID: 34921685
[TBL] [Abstract][Full Text] [Related]
4. Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aid.
Sneyd MJ; Cameron C; Cox B
BMC Cancer; 2014 May; 14():359. PubMed ID: 24884419
[TBL] [Abstract][Full Text] [Related]
5. Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data.
Shi J; Park JH; Duan J; Berndt ST; Moy W; Yu K; Song L; Wheeler W; Hua X; Silverman D; Garcia-Closas M; Hsiung CA; Figueroa JD; Cortessis VK; Malats N; Karagas MR; Vineis P; Chang IS; Lin D; Zhou B; Seow A; Matsuo K; Hong YC; Caporaso NE; Wolpin B; Jacobs E; Petersen GM; Klein AP; Li D; Risch H; Sanders AR; Hsu L; Schoen RE; Brenner H; ; ; ; ; ; ; Stolzenberg-Solomon R; Gejman P; Lan Q; Rothman N; Amundadottir LT; Landi MT; Levinson DF; Chanock SJ; Chatterjee N
PLoS Genet; 2016 Dec; 12(12):e1006493. PubMed ID: 28036406
[TBL] [Abstract][Full Text] [Related]
6. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
Landi MT; Bishop DT; MacGregor S; Machiela MJ; Stratigos AJ; Ghiorzo P; Brossard M; Calista D; Choi J; Fargnoli MC; Zhang T; Rodolfo M; Trower AJ; Menin C; Martinez J; Hadjisavvas A; Song L; Stefanaki I; Scolyer R; Yang R; Goldstein AM; Potrony M; Kypreou KP; Pastorino L; Queirolo P; Pellegrini C; Cattaneo L; Zawistowski M; Gimenez-Xavier P; Rodriguez A; Elefanti L; Manoukian S; Rivoltini L; Smith BH; Loizidou MA; Del Regno L; Massi D; Mandala M; Khosrotehrani K; Akslen LA; Amos CI; Andresen PA; Avril MF; Azizi E; Soyer HP; Bataille V; Dalmasso B; Bowdler LM; Burdon KP; Chen WV; Codd V; Craig JE; Dębniak T; Falchi M; Fang S; Friedman E; Simi S; Galan P; Garcia-Casado Z; Gillanders EM; Gordon S; Green A; Gruis NA; Hansson J; Harland M; Harris J; Helsing P; Henders A; Hočevar M; Höiom V; Hunter D; Ingvar C; Kumar R; Lang J; Lathrop GM; Lee JE; Li X; Lubiński J; Mackie RM; Malt M; Malvehy J; McAloney K; Mohamdi H; Molven A; Moses EK; Neale RE; Novaković S; Nyholt DR; Olsson H; Orr N; Fritsche LG; Puig-Butille JA; Qureshi AA; Radford-Smith GL; Randerson-Moor J; Requena C; Rowe C; Samani NJ; Sanna M; Schadendorf D; Schulze HJ; Simms LA; Smithers M; Song F; Swerdlow AJ; van der Stoep N; Kukutsch NA; Visconti A; Wallace L; Ward SV; Wheeler L; Sturm RA; Hutchinson A; Jones K; Malasky M; Vogt A; Zhou W; Pooley KA; Elder DE; Han J; Hicks B; Hayward NK; Kanetsky PA; Brummett C; Montgomery GW; Olsen CM; Hayward C; Dunning AM; Martin NG; Evangelou E; Mann GJ; Long G; Pharoah PDP; Easton DF; Barrett JH; Cust AE; Abecasis G; Duffy DL; Whiteman DC; Gogas H; De Nicolo A; Tucker MA; Newton-Bishop JA; ; ; ; ; ; ; ; ; ; Peris K; Chanock SJ; Demenais F; Brown KM; Puig S; Nagore E; Shi J; Iles MM; Law MH
Nat Genet; 2020 May; 52(5):494-504. PubMed ID: 32341527
[TBL] [Abstract][Full Text] [Related]
8. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.
Schlafly A; Pfeiffer RM; Nagore E; Puig S; Calista D; Ghiorzo P; Menin C; Fargnoli MC; Peris K; Song L; Zhang T; Shi J; Landi MT; Sampson JN
PLoS Genet; 2019 Nov; 15(11):e1008490. PubMed ID: 31730655
[TBL] [Abstract][Full Text] [Related]
10. Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors.
Vuong K; Armstrong BK; Weiderpass E; Lund E; Adami HO; Veierod MB; Barrett JH; Davies JR; Bishop DT; Whiteman DC; Olsen CM; Hopper JL; Mann GJ; Cust AE; McGeechan K;
JAMA Dermatol; 2016 Aug; 152(8):889-96. PubMed ID: 27276088
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.
Thomas M; Sakoda LC; Hoffmeister M; Rosenthal EA; Lee JK; van Duijnhoven FJB; Platz EA; Wu AH; Dampier CH; de la Chapelle A; Wolk A; Joshi AD; Burnett-Hartman A; Gsur A; Lindblom A; Castells A; Win AK; Namjou B; Van Guelpen B; Tangen CM; He Q; Li CI; Schafmayer C; Joshu CE; Ulrich CM; Bishop DT; Buchanan DD; Schaid D; Drew DA; Muller DC; Duggan D; Crosslin DR; Albanes D; Giovannucci EL; Larson E; Qu F; Mentch F; Giles GG; Hakonarson H; Hampel H; Stanaway IB; Figueiredo JC; Huyghe JR; Minnier J; Chang-Claude J; Hampe J; Harley JB; Visvanathan K; Curtis KR; Offit K; Li L; Le Marchand L; Vodickova L; Gunter MJ; Jenkins MA; Slattery ML; Lemire M; Woods MO; Song M; Murphy N; Lindor NM; Dikilitas O; Pharoah PDP; Campbell PT; Newcomb PA; Milne RL; MacInnis RJ; Castellví-Bel S; Ogino S; Berndt SI; Bézieau S; Thibodeau SN; Gallinger SJ; Zaidi SH; Harrison TA; Keku TO; Hudson TJ; Vymetalkova V; Moreno V; Martín V; Arndt V; Wei WQ; Chung W; Su YR; Hayes RB; White E; Vodicka P; Casey G; Gruber SB; Schoen RE; Chan AT; Potter JD; Brenner H; Jarvik GP; Corley DA; Peters U; Hsu L
Am J Hum Genet; 2020 Sep; 107(3):432-444. PubMed ID: 32758450
[TBL] [Abstract][Full Text] [Related]
12. Higher Nevus Count Exhibits a Distinct DNA Methylation Signature in Healthy Human Skin: Implications for Melanoma.
Roos L; Sandling JK; Bell CG; Glass D; Mangino M; Spector TD; Deloukas P; Bataille V; Bell JT
J Invest Dermatol; 2017 Apr; 137(4):910-920. PubMed ID: 27993549
[TBL] [Abstract][Full Text] [Related]
13. Melanoma risk prediction based on a polygenic risk score and clinical risk factors.
Wong CK; Dite GS; Spaeth E; Murphy NM; Allman R
Melanoma Res; 2023 Aug; 33(4):293-299. PubMed ID: 37096571
[TBL] [Abstract][Full Text] [Related]
14. No association between telomere length-related loci and number of cutaneous nevi.
Li X; Liang G; Du M; De Vivo I; Nan H
Oncotarget; 2016 Dec; 7(50):82396-82399. PubMed ID: 27637081
[TBL] [Abstract][Full Text] [Related]
15. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
16. Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
Choi J; Jia G; Wen W; Long J; Zheng W
Int J Cancer; 2020 Dec; 147(12):3416-3423. PubMed ID: 32588423
[TBL] [Abstract][Full Text] [Related]
17. Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort.
Cho HG; Ransohoff KJ; Yang L; Hedlin H; Assimes T; Han J; Stefanick M; Tang JY; Sarin KY
J Am Acad Dermatol; 2018 Jul; 79(1):36-41.e10. PubMed ID: 29499294
[TBL] [Abstract][Full Text] [Related]
18. Polygenic risk prediction models for colorectal cancer: a systematic review.
Sassano M; Mariani M; Quaranta G; Pastorino R; Boccia S
BMC Cancer; 2022 Jan; 22(1):65. PubMed ID: 35030997
[TBL] [Abstract][Full Text] [Related]
19. Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma.
Potjer TP; van der Grinten TWJ; Lakeman IMM; Bollen SH; Rodríguez-Girondo M; Iles MM; Barrett JH; Kiemeney LA; Gruis NA; van Asperen CJ; van der Stoep N
J Med Genet; 2021 Nov; 58(11):760-766. PubMed ID: 32994281
[TBL] [Abstract][Full Text] [Related]
20. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.
Newton-Bishop JA; Chang YM; Iles MM; Taylor JC; Bakker B; Chan M; Leake S; Karpavicius B; Haynes S; Fitzgibbon E; Elliott F; Kanetsky PA; Harland M; Barrett JH; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2043-54. PubMed ID: 20647408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
